Literature DB >> 19918982

Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products.

John F Carpenter1, Theodore W Randolph, Wim Jiskoot, Daan J A Crommelin, C Russell Middaugh, Gerhard Winter.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 19918982     DOI： 10.1002/jps.21989

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  35 in total

1.  Factors Governing the Precision of Subvisible Particle Measurement Methods - A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe.

Authors:  Anacelia Ríos Quiroz; Jens Lamerz; Thierry Da Cunha; Adeline Boillon; Michael Adler; Christof Finkler; Joerg Huwyler; Roland Schmidt; Hanns-Christian Mahler; Atanas V Koulov
Journal:  Pharm Res       Date:  2015-10-16       Impact factor: 4.200

2.  How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?

Authors:  Liem Andhyk Halim; Vera Brinks; Wim Jiskoot; Stefan Romeijn; Kearkiat Praditpornsilpa; Anunchai Assawamakin; Huub Schellekens
Journal:  Pharm Res       Date:  2013-11-21       Impact factor: 4.200

3.  Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding.

Authors:  Veysel Kayser; Naresh Chennamsetty; Vladimir Voynov; Bernhard Helk; Bernhardt L Trout
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

4.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

5.  Aggregation stability of a monoclonal antibody during downstream processing.

Authors:  Paolo Arosio; Giuliano Barolo; Thomas Müller-Späth; Hua Wu; Massimo Morbidelli
Journal:  Pharm Res       Date:  2011-03-30       Impact factor: 4.200

6.  Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering.

Authors:  Masakazu Fukuda; Chifumi Moriyama; Tadao Yamazaki; Yoshimi Imaeda; Akiko Koga
Journal:  Pharm Res       Date:  2015-06-16       Impact factor: 4.200

7.  Evaluation of Nanoparticle Tracking for Characterization of Fibrillar Protein Aggregates.

Authors:  Dennis T Yang; Xiaomeng Lu; Yamin Fan; Regina M Murphy
Journal:  AIChE J       Date:  2014-04-01       Impact factor: 3.993

8.  Supercritical synthesis of poly (2-dimethylaminoethyl methacrylate)/ferrite nanocomposites for real-time monitoring of protein release.

Authors:  Gunjan Bisht; M G H Zaidi
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

9.  Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.

Authors:  Karthik Pisupati; Alexander Benet; Yuwei Tian; Solomon Okbazghi; Jukyung Kang; Michael Ford; Sergei Saveliev; K Ilker Sen; Eric Carlson; Thomas J Tolbert; Brandon T Ruotolo; Steven P Schwendeman; Anna Schwendeman
Journal:  MAbs       Date:  2017-08-08       Impact factor: 5.857

10.  Thermodynamic and fluorescence analyses to determine mechanisms of IgG1 stabilization and destabilization by arginine.

Authors:  Masakazu Fukuda; Daisuke Kameoka; Takuya Torizawa; Satoshi Saitoh; Masaya Yasutake; Yoshimi Imaeda; Akiko Koga; Akihiko Mizutani
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.